260 related articles for article (PubMed ID: 19692626)
1. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
Huang XL; Fan Z; Borowski L; Rinaldo CR
Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
[TBL] [Abstract][Full Text] [Related]
3. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
4. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
5. Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.
Van Gulck ER; Vanham G; Heyndrickx L; Coppens S; Vereecken K; Atkinson D; Florence E; Kint I; Berneman ZN; Van Tendeloo V
J Virol; 2008 Apr; 82(7):3561-73. PubMed ID: 18234800
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
[TBL] [Abstract][Full Text] [Related]
7. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
8. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
[TBL] [Abstract][Full Text] [Related]
9. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
10. Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells.
Colleton BA; Huang XL; Melhem NM; Fan Z; Borowski L; Rappocciolo G; Rinaldo CR
J Virol; 2009 Jun; 83(12):6288-99. PubMed ID: 19357176
[TBL] [Abstract][Full Text] [Related]
11. Heteroclitic Peptides Increase Proliferation and Reduce Evidence of Human Immunodeficiency Virus-Specific CD8⁺ T Cell Dysfunction.
Adegoke A; Gladney K; Gallant M; Grant M
Viral Immunol; 2015 Oct; 28(8):455-63. PubMed ID: 26230145
[TBL] [Abstract][Full Text] [Related]
12. Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.
Mugaba S; Nakiboneka R; Nanyonjo M; Bugembe-Lule D; Kaddu I; Nanteza B; Tweyongyere R; Kaleebu P; Serwanga J
Vaccine; 2014 Jun; 32(30):3787-95. PubMed ID: 24837770
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1.
Smith KN; Mailliard RB; Larsen BB; Wong K; Gupta P; Mullins JI; Rinaldo CR
J Virol; 2014 Sep; 88(17):9976-90. PubMed ID: 24942586
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
15. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
mBio; 2016 May; 7(3):. PubMed ID: 27247230
[TBL] [Abstract][Full Text] [Related]
16. Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
De Keersmaecker B; Allard SD; Lacor P; Schots R; Thielemans K; Aerts JL
J Virol; 2012 Sep; 86(17):9351-60. PubMed ID: 22718823
[TBL] [Abstract][Full Text] [Related]
17. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
[TBL] [Abstract][Full Text] [Related]
18. Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.
Turk G; Ghiglione Y; Falivene J; Socias ME; Laufer N; Coloccini RS; Rodriguez AM; Ruiz MJ; Pando MÁ; Giavedoni LD; Cahn P; Sued O; Salomon H; Gherardi MM
J Virol; 2013 Jul; 87(13):7445-62. PubMed ID: 23616666
[TBL] [Abstract][Full Text] [Related]
19. Phenotype, Polyfunctionality, and Antiviral Activity of
Salido J; Ruiz MJ; Trifone C; Figueroa MI; Caruso MP; Gherardi MM; Sued O; Salomón H; Laufer N; Ghiglione Y; Turk G
Front Immunol; 2018; 9():2443. PubMed ID: 30405632
[TBL] [Abstract][Full Text] [Related]
20. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR
Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
